BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Brandão ABM, Rodriguez S, Fleck Jr AM, Marroni CA, Wagner MB, Hörbe A, Fernandes MV, Cerski CT, Coral GP. Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant. World J Clin Oncol 2022; 13(8): 688-701 [PMID: 36160465 DOI: 10.5306/wjco.v13.i8.688]
URL: https://www.wjgnet.com/2218-4333/full/v13/i8/688.htm
Number Citing Articles
1
Marcus Bahra, Ali Yahyazadeh. Surgical Strategies for Combined Hepatocellular-Cholangiocarcinoma (cHCC-CC)Cancers 2023; 15(3): 774 doi: 10.3390/cancers15030774
2
Sudha Kodali, Ashton A. Connor, David W. Victor, Maen Abdelrahim, Ahmed Elaileh, Khush Patel, Elizabeth W. Brombosz, Edward A. Graviss, Duc T. Nguyen, Susan Xu, Linda W. Moore, Mary R. Schwartz, Sadhna Dhingra, Tamneet Basra, Michelle R. Jones-Pauley, Mazen Noureddin, Constance M. Mobley, Mark J. Hobeika, Caroline J. Simon, Yee Lee Cheah, Kirk Heyne, Ahmed O. Kaseb, Ashish Saharia, A. Osama Gaber, R. Mark Ghobrial. Incidental Combined Hepatocellular-Cholangiocarcinoma in Liver Transplant Recipients: A Matched Cohort StudyTransplant International 2026; 38 doi: 10.3389/ti.2025.15298
3
Ajacio Bandeira de Mello Brandão, Santiago Rodriguez, Alfeu de Medeiros Fleck Jr, Claudio Augusto Marroni, Mário B Wagner, Alex Hörbe, Matheus V Fernandes, Carlos TS Cerski, Gabriela Perdomo Coral. Correction: Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplantWorld Journal of Clinical Oncology 2023; 14(6): 227-229 doi: 10.5306/wjco.v14.i6.227
4
Carina Teixeira, Bárbara Viamonte, Luís Graça, Hugo Pinto Marques, Inês Rego, Maria João Ribeiro. Liver Transplant After Neoadjuvant Treatment for Long-Term Survivors With Intrahepatic Cholangiocarcinoma: Does It Have a Role?Cureus 2024;  doi: 10.7759/cureus.75935